Diagnostics

The benefits of GWAS in understanding Alzheimer’s disease

Defining Alzheimer’s disease: clinical or biological

The role of phosphorylated tau in clinical trials

Using phosphorylated tau as a diagnostic tool for Alzheimer’s disease

Neurovascular dysfunction and Alzheimer’s disease pathology

Vascular abnormalities as a predictive precursor for Alzheimer’s disease

The importance of concordant treatment for Alzheimer’s disease and vascular health

Atypical presentation of Alzheimer’s disease in younger patients

Is technology the way forward in geriatric diagnosis?

Biomarker blood tests as diagnostic tool for Alzheimer’s disease

Can we predict the onset of Alzheimer’s disease using blood tests?

Representative population for Alzheimer’s disease research

Advantages of biomarker blood tests for Alzheimer’s diagnosis

The importance of early treatment and diagnosis of Alzheimer’s disease

Mild cognitive impairment: biomarker counseling, diagnosis and follow-up

Is the world prepared for dementia?